{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T21:07:28Z","timestamp":1789420048091,"version":"build-2803163510"},"reference-count":32,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","license":[{"start":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T00:00:00Z","timestamp":1777334400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"abstract":"<jats:sec>\n                    <jats:title>Objective:<\/jats:title>\n                    <jats:p>\n                      In this study, we aimed to investigate the value of\n                      <jats:sup>18<\/jats:sup>\n                      F-fluorodeoxyglucose positron emission tomography\/computed tomography (\n                      <jats:sup>18<\/jats:sup>\n                      F-FDG PET\/CT) in the differential diagnosis of nodal diffuse large B-cell lymphoma (DLBCL) and follicular lymphoma (FL) and to detect early FL transformation.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>\n                      We retrospectively enrolled 141 and 56 patients with pathologically confirmed DLBCL and FL, respectively, who underwent\n                      <jats:sup>18<\/jats:sup>\n                      F-FDG PET\/CT before treatment. The most metabolically active lymph nodes in each patient were selected to compare the imaging characteristics (including shape, size, density, adjacent tissue structures, and metabolism) between DLBCL and FL. Logistic regression was performed to identify the independent risk factors for DLBCL, and receiver operating characteristic (ROC) curve analysis was used to assess the diagnostic value of the different parameters.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      Compared with DLBCL, FL was more likely to affect the para-iliac (62.5% vs. 32.6%,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt;0.05) and inguinal (50.0% vs. 28.4%,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt;0.05) regions. Significant differences (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt;0.05) were observed between DLBCL and FL in lesion fusion, necrosis, surrounding fat stranding, adjacent organ involvement, nonround shape, SUV\n                      <jats:sub>max<\/jats:sub>\n                      , SUV\n                      <jats:sub>peak<\/jats:sub>\n                      , SUV\n                      <jats:sub>mean<\/jats:sub>\n                      , SUL\n                      <jats:sub>max<\/jats:sub>\n                      , SUL\n                      <jats:sub>peak<\/jats:sub>\n                      , SUL\n                      <jats:sub>mean<\/jats:sub>\n                      , lesion SUV\n                      <jats:sub>max<\/jats:sub>\n                      \/liver SUV\n                      <jats:sub>max<\/jats:sub>\n                      (L\/L), lesion SUV\n                      <jats:sub>max<\/jats:sub>\n                      \/mediastinum SUV\n                      <jats:sub>max<\/jats:sub>\n                      (L\/M), and total lesion glycolysis (TLG). Multivariate logistic regression analysis identified SUV\n                      <jats:sub>max<\/jats:sub>\n                      &gt;12.35, necrosis, and surrounding fat stranding as independent risk factors of DLBCL. The diagnostic model achieved an area under the curve (AUC) of 0.882, with a sensitivity of 69.5% and specificity of 94.6% for diagnosing DLBCL.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>\u00b9\u2078F-FDG PET\/CT may provide greater diagnostic value in distinguishing nodal DLBCL from FL and probably aid in the early detection of FL transformation and thereby guide timely clinical intervention, which could improve the prognosis.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/rct.0000000000001872","type":"journal-article","created":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T15:00:21Z","timestamp":1777474821000},"update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Analysis of 18F-FDG PET\/CT Imaging Features of Nodal Diffuse Large B-Cell Lymphoma and Follicular Lymphoma"],"prefix":"10.1097","volume":"50","author":[{"ORCID":"https:\/\/orcid.org\/0009-0005-4543-1669","authenticated-orcid":false,"given":"Hao","family":"Yu","sequence":"first","affiliation":[{"name":"Qingdao Medical College of Qingdao University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chaowei","family":"Li","sequence":"additional","affiliation":[{"name":"Department of radiology, PET\/CT, Qingdao Central Hospital, University of Health and Rehabilitation Sciences, Qingdao, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fei","family":"Jin","sequence":"additional","affiliation":[{"name":"Department of radiology, PET\/CT, Qingdao Central Hospital, University of Health and Rehabilitation Sciences, Qingdao, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenwen","family":"Jiang","sequence":"additional","affiliation":[{"name":"Department of radiology, PET\/CT, Qingdao Central Hospital, University of Health and Rehabilitation Sciences, Qingdao, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yudong","family":"Sui","sequence":"additional","affiliation":[{"name":"Department of radiology, PET\/CT, Qingdao Central Hospital, University of Health and Rehabilitation Sciences, Qingdao, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Zeng","sequence":"additional","affiliation":[{"name":"Department of radiology, PET\/CT, Qingdao Central Hospital, University of Health and Rehabilitation Sciences, Qingdao, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanli","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of radiology, PET\/CT, Qingdao Central Hospital, University of Health and Rehabilitation Sciences, Qingdao, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9358-2366","authenticated-orcid":false,"given":"Na","family":"Fang","sequence":"additional","affiliation":[{"name":"Department of radiology, PET\/CT, Qingdao Central Hospital, University of Health and Rehabilitation Sciences, Qingdao, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2026,9]]},"reference":[{"key":"R1-20260914","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J Clin"},{"key":"R2-20260914","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1053\/j.seminhematol.2023.11.002","article-title":"DLBCL arising from indolent lymphomas: how are they different?","volume":"60","author":"Parry","year":"2023","journal-title":"Semin Hematol"},{"key":"R3-20260914","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1038\/s41572-019-0132-x","article-title":"Follicular lymphoma","volume":"5","author":"Carbone","year":"2019","journal-title":"Nat Rev Dis Primers"},{"key":"R4-20260914","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1002\/ajh.26737","article-title":"Follicular lymphoma: 2023 update on diagnosis and management","volume":"97","author":"Jacobsen","year":"2022","journal-title":"Am J Hematol"},{"key":"R5-20260914","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1182\/blood-2014-04-516815","article-title":"Transformed follicular non-Hodgkin lymphoma","volume":"125","author":"Casulo","year":"2015","journal-title":"Blood"},{"key":"R6-20260914","doi-asserted-by":"crossref","first-page":"658234","DOI":"10.3389\/fonc.2021.658234","article-title":"Clinical application of liquid biopsy in non-Hodgkin lymphoma","volume":"11","author":"Lv","year":"2021","journal-title":"Front Oncol"},{"key":"R7-20260914","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1097\/MNM.0000000000001912","article-title":"Diagnostic value of baseline 18 F-FDG PET\/CT and peripheral blood inflammatory markers for aggressive lymphoma in non-Hodgkin\u2019s lymphoma","volume":"46","author":"Jia","year":"2025","journal-title":"Nucl Med Commun"},{"key":"R8-20260914","first-page":"7","article-title":"Value of 18F-FDG PET\/CT in discrimination between indolent and aggressive non-Hodgkin\u2019s lymphoma: a study of 328 patients","volume":"21","author":"Alobthani","year":"2018","journal-title":"Hell J Nucl Med"},{"key":"R9-20260914","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1097\/RCT.0000000000001159","article-title":"Computed tomography imaging findings for predicting histological subtypes and clinical outcomes in patients with head and neck nodal involvement of diffuse large B-cell lymphoma and follicular lymphoma","volume":"45","author":"Imada","year":"2021","journal-title":"J Comput Assist Tomogr"},{"key":"R10-20260914","doi-asserted-by":"crossref","first-page":"3048","DOI":"10.1200\/JCO.2013.53.5229","article-title":"Role of imaging in the staging and response assessment of lymphoma: consensus of the International Conference on Malignant Lymphomas Imaging Working Group","volume":"32","author":"Barrington","year":"2014","journal-title":"J Clin Oncol"},{"key":"R11-20260914","doi-asserted-by":"crossref","first-page":"216","DOI":"10.2967\/jnumed.114.149625","article-title":"18F-FDG or 3\u2019-deoxy-3\u2019-18F-fluorothymidine to detect transformation of follicular lymphoma","volume":"56","author":"Wondergem","year":"2015","journal-title":"J Nucl Med"},{"key":"R12-20260914","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1097\/RCT.0b013e3180517af3","article-title":"Preoperative evaluation of local invasion and metastatic lymph nodes of colorectal cancer and mesenteric vascular variations using multidetector-row computed tomography before laparoscopic surgery","volume":"31","author":"Kanamoto","year":"2007","journal-title":"J Comput Assist Tomogr"},{"key":"R13-20260914","doi-asserted-by":"crossref","first-page":"11073","DOI":"10.1038\/s41598-019-47453-5","article-title":"Relationship between semiquantitative 18F-fluorodeoxyglucose positron emission tomography metrics and necrosis in classical Hodgkin lymphoma","volume":"9","author":"Kahle","year":"2019","journal-title":"Sci Rep"},{"issue":"suppl 1","key":"R14-20260914","doi-asserted-by":"crossref","first-page":"122S","DOI":"10.2967\/jnumed.108.057307","article-title":"From RECIST to PERCIST: Evolving Considerations for PET response criteria in solid tumors","author":"Wahl","year":"2009","journal-title":"J Nucl Med"},{"key":"R15-20260914","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1007\/s00259-014-2961-x","article-title":"FDG PET\/CT: EANM procedure guidelines for tumour imaging: version 2.0","volume":"42","author":"Boellaard","year":"2015","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"R16-20260914","doi-asserted-by":"crossref","first-page":"3059","DOI":"10.1200\/JCO.2013.54.8800","article-title":"Recommendations for initial evaluation, staging, and response assessment of Hodgkin and non-Hodgkin lymphoma: the Lugano classification","volume":"32","author":"Cheson","year":"2014","journal-title":"J Clin Oncol"},{"key":"R17-20260914","doi-asserted-by":"crossref","first-page":"706808","DOI":"10.1155\/2015\/706808","article-title":"Positron emission tomography for the response evaluation following treatment with chemotherapy in patients affected by colorectal liver metastases: a selected review","volume":"2015","author":"Zaniboni","year":"2015","journal-title":"Gastroenterol Res Pract"},{"key":"R18-20260914","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1093\/annonc\/mdp030","article-title":"High SUV uptake on FDG-PET\/CT predicts for an aggressive B-cell lymphoma in a prospective study of primary FDG-PET\/CT staging in lymphoma","volume":"20","author":"Ngeow","year":"2009","journal-title":"Ann Oncol"},{"key":"R19-20260914","doi-asserted-by":"crossref","first-page":"4643","DOI":"10.1200\/JCO.2005.12.072","article-title":"Intensity of 18fluorodeoxyglucose uptake in positron emission tomography distinguishes between indolent and aggressive non-Hodgkin\u2019s lymphoma","volume":"23","author":"Sch\u00f6der","year":"2005","journal-title":"J Clin Oncol"},{"key":"R20-20260914","doi-asserted-by":"crossref","first-page":"3507","DOI":"10.1182\/blood-2007-06-097238","article-title":"The role of FDG-PET scans in patients with lymphoma","volume":"110","author":"Seam","year":"2007","journal-title":"Blood"},{"key":"R21-20260914","doi-asserted-by":"crossref","first-page":"109793","DOI":"10.1016\/j.ejrad.2021.109793","article-title":"Overview and recent advances in PET\/CT imaging in lymphoma and multiple myeloma","volume":"141","author":"Zanoni","year":"2021","journal-title":"Eur J Radiol"},{"key":"R22-20260914","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1002\/hon.2601","article-title":"Transformed follicular lymphoma in the rituximab era: a report from the Spanish Lymphoma Oncology Group","volume":"37","author":"M\u00e9ndez","year":"2019","journal-title":"Hematol Oncol"},{"key":"R23-20260914","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s00277-017-3151-2","article-title":"Transformed follicular lymphoma","volume":"97","author":"Fischer","year":"2018","journal-title":"Ann Hematol"},{"key":"R24-20260914","doi-asserted-by":"crossref","first-page":"3272","DOI":"10.1200\/JCO.2012.48.3990","article-title":"Rates and outcomes of follicular lymphoma transformation in the immunochemotherapy era: a report from the University of Iowa\/MayoClinic Specialized Program of Research Excellence Molecular Epidemiology Resource","volume":"31","author":"Link","year":"2013","journal-title":"J Clin Oncol"},{"key":"R25-20260914","doi-asserted-by":"crossref","first-page":"e3266","DOI":"10.1002\/hon.3266","article-title":"The role of baseline 2-[18 F]-FDG-PET\/CT metrics and radiomics features in predicting primary gastric lymphoma diagnosis","volume":"42","author":"Albano","year":"2024","journal-title":"Hematol Oncol"},{"key":"R26-20260914","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1007\/s00259-013-2443-6","article-title":"Prognostic value of whole-body metabolic tumour volume and total lesion glycolysis measured on \u00b9\u2078F-FDG PET\/CT in patients with extranodal NK\/T-cell lymphoma","volume":"40","author":"Kim","year":"2013","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"R27-20260914","doi-asserted-by":"crossref","first-page":"40","DOI":"10.2967\/jnumed.119.229450","article-title":"18F-FDG PET dissemination features in diffuse large B-cell lymphoma are predictive of outcome","volume":"6","author":"Cottereau","year":"2020","journal-title":"J Nucl Med"},{"key":"R28-20260914","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1182\/blood.V126.23.1519.1519","article-title":"Volumetric parameters on interim PET predict clinical outcomes better than SUVmax in patients with diffuse large B-cell lymphoma","volume":"126","author":"Ehsan","year":"2015","journal-title":"Blood"},{"key":"R29-20260914","doi-asserted-by":"crossref","first-page":"734","DOI":"10.3390\/metabo13060734","article-title":"The metabolism and immune environment in diffuse large B-cell lymphoma","volume":"13","author":"Wu","year":"2023","journal-title":"Metabolites"},{"key":"R30-20260914","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1182\/asheducation-2007.1.216","article-title":"Clinical features, prognosis and treatment of follicular lymphoma","volume":"2007","author":"Salles","year":"2007","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"R31-20260914","first-page":"368","article-title":"Staging non-Hodgkin lymphoma","volume":"55","author":"Armitage","year":"2005","journal-title":"CA Cancer J Clin"},{"key":"R32-20260914","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1007\/s00259-021-05626-3","article-title":"Machine learning in the differentiation of follicular lymphoma from diffuse large B-cell lymphoma with radiomic [18F]FDG PET\/CT features","volume":"49","author":"de Jesus","year":"2022","journal-title":"Eur J Nucl Med Mol Imaging"}],"container-title":["Journal of Computer Assisted Tomography"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/RCT.0000000000001872","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T21:00:19Z","timestamp":1789419619000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/RCT.0000000000001872"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,28]]},"references-count":32,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/rct.0000000000001872","relation":{},"ISSN":["1532-3145","0363-8715"],"issn-type":[{"value":"1532-3145","type":"electronic"},{"value":"0363-8715","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4,28]]},"assertion":[{"value":"2025-10-23","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-04-05","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}